CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, named its new Board of Directors led by co-founder Jérôme Koch, in line with recent bridge financing organized ...

Berlin (ots) - Der Frühling steht vor der Tür, doch die aktuelle Grippewelle hat Deutschland weiterhin fest im Griff. In der ...

Arv­inas and Pfiz­er’s tar­get­ed pro­tein de­grad­er has not man­aged to dis­tin­guish it­self from oth­er, sim­i­lar breast can­cer drugs, ac­cord­ing to piv­otal da­ta re­ ...

Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...

Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects. Pfizer and Arvinas’ investigational PRTOAC degrader vepdegestrant can improve progression-free survival ...

Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ups and downs in between, after it took a hammering in the past couple ...

Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...

Im sechsten Bundesligaspiel in Serie bleibt Freiburg ohne Gegentor. Sowohl Leipzig als auch die Breisgauer hatten aber auch kaum Chancen. Durch das 0:0 am 25. Spieltag bleiben die Breisgauer eben ...

Der Sport-Club Freiburg empfängt heute RB Leipzig. Der Anstoß ist um 18:30 Uhr im Europa-Park Stadion. SPORT1 erklärt Ihnen, wo Sie das Spiel im TV, Livestream und Liveticker verfolgen können.

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment is a new chief internal medicine officer. In the role, James List ...

The Smartest Dividend Stocks to Buy With $2,000 Right Now ...

It wasn't all positive for Pfizer and BioNTech on the patent front this week, though. In Germany, the Düsseldorf Regional Court ruled for Moderna in a case that also dates back to 2022.